Page last updated: 2024-08-26

1,4-dihydropyridine and Cancer of Ovary

1,4-dihydropyridine has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arora, KK; Diedrich, K; Katzur, AC; Ortmann, O; Schultze-Mosgau, A; Stojilkovic, SS1

Other Studies

1 other study(ies) available for 1,4-dihydropyridine and Cancer of Ovary

ArticleYear
Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells.
    Molecular human reproduction, 2000, Volume: 6, Issue:5

    Topics: Adenosine Triphosphate; Calcium; Calcium Channel Blockers; Cell Division; Dihydropyridines; Enzyme Activation; Enzyme Inhibitors; Female; Glycerophospholipids; Humans; Nifedipine; Ovarian Neoplasms; Phospholipase D; Potassium; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Thapsigargin; Tumor Cells, Cultured; Uridine Triphosphate

2000